Bass Connections Team Leader for Closing the Gap on Health Disparities and Outcomes in Hypertension
As of 2024 · Last known relationship
Neha Pagidipati is a Duke cardiologist and faculty leader focused on preventing cardiometabolic disease through coordinated care, clinical research, and implementation science. She is an Associate Professor of Medicine, a member of the Duke Clinical Research Institute, director of the Duke Cardiometabolic Prevention Clinic, and Associate Program Director of the DCRI Fellowship. Her research addresses lifestyle modification, weight management, lipid disorders, hypertension, and diabetes, using clinical trials, outcomes research, and implementation research. She has conducted cardiometabolic prevention research since 2011 and is an NIH K12 scholar in Implementation and Dissemination Science. After graduating from Harvard College and Harvard Medical School, she trained in internal medicine and Global Women’s Health at Brigham and Women’s Hospital, including research on cardiovascular prevention in women in India, then completed Duke cardiology fellowship and served as DCRI Chief Research Fellow from 2016 to 2017.
Each topic is linked to its supporting source in Sources.
Training includes Bass Connections Team Leader for Closing the Gap on Health Disparities and Outcomes in Hypertension, Chief Research Fellow at the Duke Clinical Research Institute, Cardiology fellowship at Duke University School of Medicine, and Global Women’s Health research fellowship at Brigham and Women’s Hospital, plus 15 more records.
Explore education and trainingAs of 2024
As of 2017
As of 2017
As of 2013
As of 2013
As of 2011
As of 2008
As of 2023
As of 2017
As of 2008
Currently an NIH K12 scholar in Implementation and Dissemination Science[8]
Publication: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome in Circulation[8]
From 2026
Publication: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome in the Journal of the American College of Cardiology[8]
From 2026
Publication: A Single Center Comparison of Obesity Management Medications and Metabolic Bariatric Surgery in Patients with Left Ventricular Assist Device and Obesity[8]
From 2026
Publication: Association of Hyperlipidemia and Cardiovascular-Kidney-Metabolic Risk Factor Severity With Incidental Coronary Artery Calcium[8]
From 2026
Publication: Cardiovascular Risk Factors - Hypertension[8]
From 2026
Publication: Cardiovascular Risk Factors - Lifestyle Modifications[8]
From 2026
Publication: Design and Rationale of the pERSonalized cardIovascuLar dIsease prEvention, treatmeNt, and CarE (RESILIENCE) study[8]
From 2026
Publication: Practicalities of Obesity Management for the Cardiologist: A Quick Start Companion to the CKM Guidelines[8]
From 2026
Publication: South Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography Angiography[8]
From 2026
Publication: Wherever, Whenever, and However It Is Found: Atherosclerosis Is Informative[8]
From 2026
Research interests include lifestyle modification, weight management, lipid disorders, hypertension, and diabetes[11]
Research methods include clinical trials, outcomes research, and implementation research[11]
Research on cardiometabolic disease prevention since 2011[11]
From 2011
Served as a study clinician on the EXSCEL trial[8]
Site investigator for the Baseline Health Study in collaboration with Verily Life Sciences[8]
Studied cardiovascular disease prevention in women in India during the Global Women's Health fellowship[11]